Highlights AVEO Pharmaceuticals, Inc. Börse Stuttgart

Equities

VPA

US0535881090

Delayed Börse Stuttgart Other stock markets 08:03:53 05/10/2021 pm IST			5-day change	1st Jan Change
5.28 ^EUR	-0.19%		-10.02%	+20.93%

25/03	AVEO Pharmaceuticals, Inc. Announces Executive Changes	CI
06/02	Aveo Oncology Announces Publication of Long-Term Survival in Patients with Relapsed/Refractory Advanced Renal Cell Carcinoma Treated with Tivozanib: Analysis of the Phase Iii Tivo-3 Trial in the Oncologist	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Aveo Oncology Announces Publication of Long-Term Survival in Patients with Relapsed/Refractory Advanced Renal Cell Carcinoma Treated with Tivozanib: Analysis of the Phase Iii Tivo-3 Trial in the Oncologist	06/02	CI
AVEO Oncology Enrolls First Patient in Pivotal FIERCE-HN Clinical Trial to Evaluate Ficlatuzumab in Combination with ERBITUX® in Patients with HPV-negative Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)	16/01	CI
AVEO Oncology Announces Completion of Enrollment in Pivotal Phase 3 TiNivo-2 Study of FOTIVDA(R) in Combination with OPDIVO(R) in Advanced Renal Cell Carcinoma	27/23/27	CI
AVEO Completes Acquisition by LG Chem	20/23/20	MT
LG Chem Acquires US Biopharma Firm AVEO Pharmaceuticals	20/23/20	MT
AVEO Pharmaceuticals, Inc. Announces Management Changes	20/23/20	CI
AVEO Oncology Appoints Martin Birkhofer as Its Chief Medical Officer	20/23/20	CI
LG Chem, Ltd. completed the acquisition of AVEO Pharmaceuticals, Inc. from a group of shareholders.	19/23/19	CI
AVEO Pharmaceuticals Receives CFIUS Clearance for LG Chem Merger	19/23/19	MT
AVEO Pharmaceuticals : Merger Agreement - Form 8-K	18/23/18	PU
AVEO Pharmaceuticals Stockholders Approve LG Chem Merger	06/23/06	MT
AVEO Pharmaceuticals : Merger Agreement - Form 8-K	02/22/02	PU
Earnings Flash (AVEO) AVEO PHARMACEUTICALS Reports Q3 Revenue $30.4M, vs. Street Est of $29.9M	08/22/08	MT
AVEO Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	08/22/08	CI
Aveo Pharmaceuticals, Inc. Withdraws Earnings Guidance for the Year 2022	08/22/08	CI
LG Chem to Acquire AVEO Pharmaceuticals for $566 Million	19/22/19	MT
Health Care Up Amid Earnings, Deals -- Health Care Roundup	19/22/19	DJ
AVEO Pharma Shares Soar After LG Chem Takeover News	19/22/19	DJ
AVEO Pharmaceuticals to Be Acquired by LG Chem in $566 Million All-Cash Deal; Shares Surge	18/22/18	MT
LG Chem to Acquire AVEO Pharmaceuticals for $566 Million	18/22/18	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights AVEO Pharmaceuticals, Inc. Börse Stuttgart

Equities

VPA

US0535881090

Highlights

Filters